Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | EPHX1 | P07099 | 8/20 | 0.73 |
| ▸ | EPHX2 | P34913 | 5/20 | 0.61 |
| ▸ | PRMT1 | Q99873 | 1/20 | 0.56 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.52 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.52 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.52 |
| ▸ | MEN1 | O00255 | 1/20 | 0.50 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.50 |
| ▸ | CNR2 | P34972 | 1/20 | 0.49 |
| ▸ | CASP2 | P42575 | 1/20 | 0.46 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL14198101 | 0.97 | EPHX1 (0.68) | EPHX1EPHX2PRMT1KDM4EMAPK1 | |
| SCHEMBL8392636 | 0.93 | EPHX1 (0.86) | EPHX1EPHX2CASP2 | |
| SCHEMBL8391736 | 0.93 | EPHX1 (0.86) | EPHX1EPHX2CASP2 | |
| SCHEMBL8848185 | 0.93 | EPHX1 (0.86) | EPHX1EPHX2CASP2 | |
| SCHEMBL25270954 | 0.93 | EPHX1 (0.86) | EPHX1EPHX2CASP2 | |
| SCHEMBL25227718 | 0.93 | EPHX1 (0.86) | EPHX1EPHX2CASP2 | |
| SCHEMBL11236288 | 0.93 | EPHX1 (0.86) | EPHX1EPHX2CASP2 | |
| SCHEMBL25274521 | 0.93 | EPHX1 (0.86) | EPHX1EPHX2CASP2 | |
| SCHEMBL8392235 | 0.93 | EPHX1 (0.86) | EPHX1EPHX2CASP2 | |
| SCHEMBL25836841 | 0.93 | EPHX1 (0.86) | EPHX1EPHX2CASP2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-4929724-A | PHOSPHOROUS-NITROGEN DIMERIZATION CATALYSTS | BAYER AKTIENGESELLSCHAFT (DE) | 1990-05-29 | — | — | US | disclosed |